| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/26/2009 | WO2009016462A3 Substituted bicyclolactam compounds |
| 03/26/2009 | WO2008137633A3 Methods of modulating cellular homeostatic pathways and cellular survival |
| 03/26/2009 | WO2008058269A3 Compounds and methods for modulating protein trafficking |
| 03/26/2009 | US20090082446 Use of Hydroxyoleic acid and related compounds in the manufacture of drugs |
| 03/26/2009 | US20090082441 Deuterium-enriched tesaglitazar |
| 03/26/2009 | US20090082420 Deuterium-enriched vildagliptin |
| 03/26/2009 | US20090082412 Deuterium-enriched deferasirox |
| 03/26/2009 | US20090082410 Constitutively translocating cell line |
| 03/26/2009 | US20090082405 Deuterium-enriched pioglitazone |
| 03/26/2009 | US20090082392 Substituted Carboxylic Acids |
| 03/26/2009 | US20090082390 Piperidine compounds for use as orexin receptor antagonist |
| 03/26/2009 | US20090082376 Deuterium-enriched alogliptin |
| 03/26/2009 | US20090082367 Triazole derivative or a salt thereof |
| 03/26/2009 | US20090082359 5-pyridinone substituted indazoles |
| 03/26/2009 | US20090082331 S1p receptor modulating compounds and use thereof |
| 03/26/2009 | US20090082329 Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors |
| 03/26/2009 | US20090082309 Inhibiting dipeptidylpeptidase proteolysis of glucagon-like peptide 1 by conjointly administering to the animal metformin and an inhibitor of dipeptidylpeptidase IV; treating Type II diabetes but not sufficient to suppress the immune system of the animal |
| 03/26/2009 | US20090082307 Culturing Lac Z-Y+ E. coli cell on glycerol and glucose in presence of lactose as exogenous precursor and isopropyl beta -D-thiogalactoside as inducer under conditions inducing the internalization according to a mechanism of active transport of exogenous precursor by cell and production of lactose |
| 03/26/2009 | US20090082302 Modulation of eif4e-bp2 expression |
| 03/26/2009 | US20090082285 Adiponectin expression promoter |
| 03/26/2009 | US20090082283 Dipeptides for Prevention of Muscle Breakdown and Microbial Infection |
| 03/26/2009 | US20090082266 Conjugate of water-soluble hyaluronic acid modification product with glp-a analogue |
| 03/26/2009 | US20090082255 by addition of surfactants providing a high long-term stability due to stress; storage stability to hydrophobic aggregation nuclei for several months under temperature stress; for the treatment of diabetes; FDA Orange book listed patent for insulin glargine recombinant |
| 03/26/2009 | US20090081732 Antibodies to human il-1beta |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081315 Iron composition containing milk protein |
| 03/26/2009 | US20090081314 Glycemic Control, Diabetes Treatment, and Other Treatments with Acetyl Cholinesterase Inhibitors |
| 03/26/2009 | US20090081300 Agent for use in the case of fructose intolerance |
| 03/26/2009 | US20090081299 Sustained release of apo a-i mimetic peptides and methods of treatment |
| 03/26/2009 | US20090081293 Sustained release of apo a-i mimetic peptides and methods of treatment |
| 03/26/2009 | US20090081201 Methods for Identifying Compounds For the Treatment of Type 1 Diabetes |
| 03/26/2009 | US20090081197 Methods for Selection of Melanocortin Receptor-Specific Agents for Treatment of Obesity |
| 03/26/2009 | US20090081168 Method of forming a peptide-receptor complex with zsig33 |
| 03/26/2009 | US20090081123 Pharmaceutical compounds |
| 03/26/2009 | CA2699854A1 Use of compounds comprising phosphorous for the treatment of cachexia |
| 03/26/2009 | CA2699760A1 Compositions and methods for diagnosis and treatment of type 2 diabetes |
| 03/26/2009 | CA2699417A1 S1p receptor modulating compounds and use thereof |
| 03/26/2009 | CA2699292A1 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 03/26/2009 | CA2699275A1 4-sulfonylpiperidine derivative |
| 03/26/2009 | CA2697551A1 Piperidine derivatives as modulators of gpr119 activity |
| 03/26/2009 | CA2696508A1 Diacylglycerol acyltransferase inhibitors |
| 03/26/2009 | CA2696298A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 03/26/2009 | CA2693807A1 Foodstuff composition to improve digestibility of foodstuff lipids |
| 03/25/2009 | EP2039779A1 Screening method |
| 03/25/2009 | EP2039695A1 Bicyclic heterocyclic compound and use thereof |
| 03/25/2009 | EP2039366A1 Composition containing peptide as the active ingredient |
| 03/25/2009 | EP2039365A1 Visceral fat accumulation inhibitor, and agent for promoting the increase in and/or inhibiting the decrease in blood adiponectin level |
| 03/25/2009 | EP2039361A2 Use of immunomodulatory compounds |
| 03/25/2009 | EP2039357A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 03/25/2009 | EP2039353A1 Reduced coenzyme q10-containing composition and method for producing the same |
| 03/25/2009 | EP2038267A2 Thiadiazolidinone inhibitors of ptpase |
| 03/25/2009 | EP2038259A1 Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same |
| 03/25/2009 | EP2038256A1 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ']-bipyridine and its use as a medicament |
| 03/25/2009 | EP2038255A2 Pharmaceutical use of substituted piperidine carboxamides |
| 03/25/2009 | EP2037950A2 Further medical uses of antisecretory protein |
| 03/25/2009 | EP2037928A2 Methods for treating atherosclerosis |
| 03/25/2009 | EP2037926A1 Use of pkc inhibitors in diabetic complications |
| 03/25/2009 | EP2037911A2 Composition comprising chrysine and cholic acid for reduction of weight, acceleration of lipolysis and/or restriction of calories |
| 03/25/2009 | EP2037888A2 Active agent formulations, methods of making, and methods of use |
| 03/25/2009 | EP2037740A2 Compositions and methods to enhance reverse cholesterol transport |
| 03/25/2009 | EP2000469A9 Acylaminopiperidine compound |
| 03/25/2009 | EP2000145A9 Ameliorating agent for metabolic syndrome |
| 03/25/2009 | EP1789403B1 N-(phenyl-oxazol-4-ylmethoxymethyl)-cyclohexyl.succinic acid amide derivatives and related compounds which are used as ppar-ligands (peroxisome proliferator activated receptors) for the treatment of hyperlipidaemie and diabetes |
| 03/25/2009 | EP1755401A4 Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport |
| 03/25/2009 | EP1718624B1 Benzamide derivatives and their use as glucokinase activating agents |
| 03/25/2009 | EP1636218B1 Thiazolylpiperidine derivatives as mtp inhibitors |
| 03/25/2009 | EP1472228B1 Process for the manufacture of hmg-coa reductase inhibitors |
| 03/25/2009 | EP1460999B1 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 03/25/2009 | EP1377579B1 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 03/25/2009 | EP1299421B1 Antibodies to human mcp-1 |
| 03/25/2009 | EP1287035B1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/25/2009 | CN101395153A Use of adenosine A1 and/or dual A1/A2B agonists for production of medicaments for treating diseases |
| 03/25/2009 | CN101395145A Novel heterocyclic cycloalkyl derivatives, method for the preparation thereof, and pharmaceutical compositions containing the same |
| 03/25/2009 | CN101395130A Acyclic sulfamide derivatives |
| 03/25/2009 | CN101394858A Intestinal alpha-glucosidase inhibitors and a process for the isolation and use thereof |
| 03/25/2009 | CN101394848A Use of vildagliptin for the treatment of diabetes |
| 03/25/2009 | CN101392015A Triterpene saponin in camellia seeds, preparation method and medical use thereof |
| 03/25/2009 | CN101392012A Partial and full agonists of A1 adenosine receptors |
| 03/25/2009 | CN101392001A Carboxamides derivates, preparation method thereof and use on medicine |
| 03/25/2009 | CN101391101A New use of cyclodextrin glucanotransferase |
| 03/25/2009 | CN101391095A Production technique of bone peptide calcium |
| 03/25/2009 | CN101391092A Chinese patent medicine for curing diabetes and preparation method thereof |
| 03/25/2009 | CN101391076A Huidouba extract traditional Chinese medicine preparation for treating diabetes |
| 03/25/2009 | CN101391072A Traditional Chinese medicine for treating diabetic diarrhea |
| 03/25/2009 | CN101391071A Traditional Chinese medicine for treating diabetic ocular fundus diseases |
| 03/25/2009 | CN101391037A Medicine composition for treating diabetes of deficiency of both qi and yin with blood stasis and preparation method thereof |
| 03/25/2009 | CN101391033A Internal medicine for treating diabetes |
| 03/25/2009 | CN101391032A Medicine composition for preventing the birth defect and improving the memory |
| 03/25/2009 | CN101391031A Medicine composition for preventing the birth defect and improving the memory |
| 03/25/2009 | CN101391030A Medicine composition for preventing the birth defect and improving the memory |
| 03/25/2009 | CN101391029A Medicine composition for preventing the birth defect and improving the memory |
| 03/25/2009 | CN101391028A Medicine composition for preventing the birth defect and improving the memory |
| 03/25/2009 | CN101391027A Medicine composition for preventing the birth defect and improving the memory |
| 03/25/2009 | CN101391026A Medicine composition for preventing the birth defect and improving the memory |
| 03/25/2009 | CN101391023A Medicine composition for preventing the birth defect and improving the memory |
| 03/25/2009 | CN101391022A Medicine composition for preventing the birth defect and improving the memory |
| 03/25/2009 | CN101391009A Medicine composition for treating diabetic nephropathy of deficiency of both qi and yin and accumulation of blood stasis and preparation method thereof |
| 03/25/2009 | CN101391002A Traditional Chinese medicine for treating hyperlipemia |
| 03/25/2009 | CN101390993A Traditional Chinese medicine for treating diabetic foot |
| 03/25/2009 | CN101390985A Traditional Chinese medicine for treating diabetes acral necrosis |